Ray Future Growth
Future criteria checks 4/6
Ray is forecast to grow earnings and revenue by 55.8% and 19.4% per annum respectively. EPS is expected to grow by 55.4% per annum. Return on equity is forecast to be 16.7% in 3 years.
Key information
55.8%
Earnings growth rate
55.4%
EPS growth rate
Medical Equipment earnings growth | 33.6% |
Revenue growth rate | 19.4% |
Future return on equity | 16.7% |
Analyst coverage | Low |
Last updated | 20 May 2024 |
Recent future growth updates
Recent updates
Market Still Lacking Some Conviction On Ray Co., Ltd. (KOSDAQ:228670)
May 25The Returns On Capital At Ray (KOSDAQ:228670) Don't Inspire Confidence
Mar 14Is Ray (KOSDAQ:228670) Using Too Much Debt?
Mar 16What Type Of Shareholders Make Up Ray Co., Ltd.'s (KOSDAQ:228670) Share Registry?
Feb 21With A Return On Equity Of 13%, Has Ray Co., Ltd.'s (KOSDAQ:228670) Management Done Well?
Feb 02We Wouldn't Rely On Ray's (KOSDAQ:228670) Statutory Earnings As A Guide
Jan 14If You Had Bought Ray (KOSDAQ:228670) Shares A Year Ago You'd Have Earned 11% Returns
Dec 27Here's Why Ray (KOSDAQ:228670) Can Manage Its Debt Responsibly
Dec 08Has Ray (KOSDAQ:228670) Got What It Takes To Become A Multi-Bagger?
Nov 19Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 242,000 | 25,500 | 27,000 | 38,500 | 2 |
12/31/2025 | 222,175 | 29,675 | 20,000 | 30,500 | 4 |
12/31/2024 | 150,350 | 10,350 | 53,000 | 32,500 | 2 |
3/31/2024 | 143,226 | -4,452 | -37,230 | -34,649 | N/A |
12/31/2023 | 145,882 | -2,146 | -25,443 | -22,791 | N/A |
9/30/2023 | 145,143 | 7,518 | -23,985 | -20,132 | N/A |
6/30/2023 | 139,591 | 6,462 | -46,909 | -19,720 | N/A |
3/31/2023 | 131,396 | 5,346 | -41,773 | -10,358 | N/A |
12/31/2022 | 128,998 | 7,957 | -40,940 | -8,231 | N/A |
9/30/2022 | 108,356 | -5,628 | -54,083 | -4,501 | N/A |
6/30/2022 | 100,533 | -2,984 | -19,860 | 8,764 | N/A |
3/31/2022 | 93,026 | 1,241 | -13,752 | 10,660 | N/A |
12/31/2021 | 90,336 | -13 | -12,233 | 11,172 | N/A |
9/30/2021 | 84,681 | 12,727 | 9,300 | 15,001 | N/A |
6/30/2021 | 73,676 | 9,988 | 8,771 | 15,267 | N/A |
3/31/2021 | 57,803 | 4,645 | 921 | 8,407 | N/A |
12/31/2020 | 55,205 | 7,904 | -4,416 | 2,903 | N/A |
9/30/2020 | 57,260 | 7,979 | -5,194 | 2,262 | N/A |
6/30/2020 | 61,781 | 8,891 | -5,777 | -874 | N/A |
3/31/2020 | 71,986 | 12,340 | 125 | 3,760 | N/A |
12/31/2019 | 73,109 | 11,555 | 2,546 | 6,040 | N/A |
9/30/2019 | 69,512 | 10,843 | 1,694 | 4,973 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: A228670 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.5%).
Earnings vs Market: A228670 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: A228670 is expected to become profitable in the next 3 years.
Revenue vs Market: A228670's revenue (19.4% per year) is forecast to grow faster than the KR market (10.3% per year).
High Growth Revenue: A228670's revenue (19.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: A228670's Return on Equity is forecast to be low in 3 years time (16.7%).